FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q82854230> ?p ?o ?g. }

• Q82854230 description "artículu científicu espublizáu en marzu de 2010" @default.
• Q82854230 description "scientific article published on 01 March 2010" @default.
• Q82854230 description "wetenschappelijk artikel" @default.
• Q82854230 description "наукова стаття, опублікована в березні 2010" @default.
• Q82854230 name "Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in" @default.
• Q82854230 name "Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in" @default.
• Q82854230 type Item @default.
• Q82854230 label "Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in" @default.
• Q82854230 label "Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in" @default.
• Q82854230 prefLabel "Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in" @default.
• Q82854230 prefLabel "Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in" @default.
• Q82854230 P1433 Q82854230-0936B794-1446-489E-8183-2622CA3DC4AF @default.
• Q82854230 P1476 Q82854230-0368F11B-23D8-4F39-BF2A-1BDD41177B6C @default.
• Q82854230 P2093 Q82854230-2D2A86EA-AA4D-4032-90DD-33B33B4D9715 @default.
• Q82854230 P2093 Q82854230-5F614BF7-E640-4728-A1FC-E47B9504C237 @default.
• Q82854230 P2093 Q82854230-BBD855CF-1712-4825-A847-8C0D55260581 @default.
• Q82854230 P2860 Q82854230-0BB9932A-BC7B-4D23-B965-E440F156D300 @default.
• Q82854230 P2860 Q82854230-12E9FC67-53F6-4D7F-8858-AC14E0DC35C5 @default.
• Q82854230 P2860 Q82854230-19767B08-E2A9-4D19-B0D5-317D2561D9D2 @default.
• Q82854230 P2860 Q82854230-3754D831-BC8B-4049-822F-EF4593F2E69C @default.
• Q82854230 P2860 Q82854230-382291EF-6398-4362-9513-464A78D2BAF0 @default.
• Q82854230 P2860 Q82854230-3B9329DE-893D-4AAE-9EE1-2B7E0EDBAA21 @default.
• Q82854230 P2860 Q82854230-416EE7CA-E4FF-4994-83BC-A06843CBA4DD @default.
• Q82854230 P2860 Q82854230-42224B70-3993-45A1-AEC1-26FFFD67F3EF @default.
• Q82854230 P2860 Q82854230-4C4F80F1-C784-4A67-8BB0-E1D8CE999DAB @default.
• Q82854230 P2860 Q82854230-62CA2440-4F70-4A56-911B-5FE968791FCE @default.
• Q82854230 P2860 Q82854230-64FFD18E-FF0F-4448-A434-86422A1772C5 @default.
• Q82854230 P2860 Q82854230-6AECF98C-2818-42DD-A889-6F62451BC3F2 @default.
• Q82854230 P2860 Q82854230-6C60835A-0F9D-4111-97D3-C6271020D529 @default.
• Q82854230 P2860 Q82854230-71DC9CB6-8C02-434A-9D37-92F70EEABF5B @default.
• Q82854230 P2860 Q82854230-7BC69AED-1C19-47CB-BC4D-68AEBCFD7F2A @default.
• Q82854230 P2860 Q82854230-7BD61865-8F52-46E2-B0C2-7C3599429C75 @default.
• Q82854230 P2860 Q82854230-7D822B69-935A-4085-A4B8-39F12AB21DFF @default.
• Q82854230 P2860 Q82854230-7E3A1244-6857-4C15-BEF4-D0BF79F85805 @default.
• Q82854230 P2860 Q82854230-83CB4CFC-5F89-49B7-922F-76F50F0CABCF @default.
• Q82854230 P2860 Q82854230-8A5931BE-5B7D-4452-A519-22B2E019C7D2 @default.
• Q82854230 P2860 Q82854230-8B168430-1A84-4984-B0CB-07671152469D @default.
• Q82854230 P2860 Q82854230-900B4AB7-66AF-4190-AD3E-9A7B50C7A4FA @default.
• Q82854230 P2860 Q82854230-9E954A45-33FD-4A4B-A28E-BFA7F31AF5FE @default.
• Q82854230 P2860 Q82854230-A8528262-F07E-454E-9766-CB1D96ABA6F6 @default.
• Q82854230 P2860 Q82854230-B9396CF6-E6AB-432D-98AF-6D34EC47A88E @default.
• Q82854230 P2860 Q82854230-C2A9D215-1C6A-44F6-81FC-A4D5F98BD8F7 @default.
• Q82854230 P2860 Q82854230-C66C303D-AD3A-49C0-8167-F8265C713138 @default.
• Q82854230 P2860 Q82854230-CB15F3E7-B372-46F1-9918-BA0B4A0E4064 @default.
• Q82854230 P2860 Q82854230-D87CF4E0-020E-4986-83B9-2585EF32E059 @default.
• Q82854230 P2860 Q82854230-D92C8BB8-4901-4FC3-BA4D-C9DA0F411D1E @default.
• Q82854230 P2860 Q82854230-DA2B16E6-C278-4680-9034-2E92D5562C74 @default.
• Q82854230 P2860 Q82854230-DA778654-88C6-46EB-957F-70BCE2A7D4EF @default.
• Q82854230 P2860 Q82854230-DF61656B-AA65-4E9C-A442-F2231A9F9FB4 @default.
• Q82854230 P2860 Q82854230-E35936D5-CD1B-4225-920D-D2E3DE2968D6 @default.
• Q82854230 P2860 Q82854230-EEA7E3A6-74CF-4F0E-AB00-83AC92C97356 @default.
• Q82854230 P2860 Q82854230-F05B1BD4-4721-433C-AEC2-90508322184A @default.
• Q82854230 P2860 Q82854230-F773B862-A29F-4390-8DF5-6C7420A1EE52 @default.
• Q82854230 P304 Q82854230-4C5771CB-06CA-4897-91FF-934B2B9BDF20 @default.
• Q82854230 P31 Q82854230-AEA71D83-7A87-4462-82E7-DD03187D5B8F @default.
• Q82854230 P356 Q82854230-83EB42A7-B30C-4DA1-AECB-05D6E4342CA7 @default.
• Q82854230 P433 Q82854230-DCD2F54A-7E89-406E-9920-EF1C23FFBB29 @default.
• Q82854230 P478 Q82854230-89E3E8C2-104A-4151-ACB3-EB233F1AF3C0 @default.
• Q82854230 P50 Q82854230-6F197C59-3011-4B8E-A169-44C93C5C7170 @default.
• Q82854230 P577 Q82854230-ED7539BE-76A3-46D9-B7F4-0D4919E4456F @default.
• Q82854230 P698 Q82854230-DFC818C8-3290-44CB-AEAC-D95D1515CA2B @default.
• Q82854230 P932 Q82854230-0104AC49-AD1A-492D-8DCA-B1253A4CBD0A @default.
• Q82854230 P356 JM901618D @default.
• Q82854230 P698 20146482 @default.
• Q82854230 P1433 Q900316 @default.
• Q82854230 P1476 "Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson's disease" @default.
• Q82854230 P2093 "Balaram Ghosh" @default.
• Q82854230 P2093 "Maarten E A Reith" @default.
• Q82854230 P2093 "Tamara Antonio" @default.
• Q82854230 P2860 Q22337213 @default.
• Q82854230 P2860 Q27860680 @default.
• Q82854230 P2860 Q28260663 @default.
• Q82854230 P2860 Q29614763 @default.
• Q82854230 P2860 Q29618017 @default.
• Q82854230 P2860 Q29619903 @default.
• Q82854230 P2860 Q32120625 @default.
• Q82854230 P2860 Q33183051 @default.
• Q82854230 P2860 Q33265648 @default.
• Q82854230 P2860 Q33543091 @default.
• Q82854230 P2860 Q33639920 @default.
• Q82854230 P2860 Q34217223 @default.
• Q82854230 P2860 Q34242473 @default.
• Q82854230 P2860 Q34429102 @default.
• Q82854230 P2860 Q34502910 @default.
• Q82854230 P2860 Q34529356 @default.
• Q82854230 P2860 Q35100331 @default.
• Q82854230 P2860 Q35545150 @default.
• Q82854230 P2860 Q36196507 @default.
• Q82854230 P2860 Q39992327 @default.
• Q82854230 P2860 Q40317881 @default.
• Q82854230 P2860 Q40338831 @default.
• Q82854230 P2860 Q40470377 @default.
• Q82854230 P2860 Q40533387 @default.
• Q82854230 P2860 Q41095404 @default.
• Q82854230 P2860 Q41912769 @default.
• Q82854230 P2860 Q42638052 @default.
• Q82854230 P2860 Q44772844 @default.
• Q82854230 P2860 Q46259565 @default.
• Q82854230 P2860 Q46541429 @default.
• Q82854230 P2860 Q48450930 @default.

• next